X

Bis zu 814 Euro pro Jahr: Gebühren oder Rendite? Du entscheidest.

Laut Stiftung Warentest (12/2025) zahlst du beim 'Kostensieger' finanzen.net ZERO jährlich bis zu 814 Euro weniger Gebühren als bei anderen Anbietern. Wechsle jetzt zum Broker von finanzen.net und spare bei jedem Trade!

Depot eröffnen Mehr zum Test

Nicht mehr anzeigen

BioAge Labs Aktie

Kaufen

Verkaufen

16,40 EUR -0,50 EUR -2,96 %

11:33:14

STU

19,72 USD -0,57 USD -2,81 %

nachbörslich10:12:41

BTT

BioAge Labs jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Smartphone

Marktkap.706,32 Mio. EUR

Div. Rendite0,00%

WKNA40D7P

ISINUS09077V1008

SymbolBIOA

BioAge Labs Aktien News

Sortieren:Datum Meistgelesen

17.03.25PR NewswireBioArctic receives Orphan Drug Designation for exidavnemab the US

17.03.25PR NewswireBioArctic receives Orphan Drug Designation for exidavnemab the US

11.03.25PR NewswireFinal Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA

WerbungBioAge Labs-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

05.03.25PR NewswireBIOA Deadline: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

28.02.25PR NewswireBIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

25.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA

11.02.25PR NewswireLevi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA

04.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA

29.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA

20.01.25PR NewswireBIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm

19.01.25PR NewswireBIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11.01.25PR NewswireBIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

10.01.25PR NewswireBIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

09.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against BioAge Labs, Inc. - BIOA

09.01.25PR NewswireBIOA INVESTOR ALERT: Edelson Lechtzin LLP Urges BioAge Labs, Inc. (NASDAQ: BIOA) Shareholders to Consult Legal Counsel About the Impending Lead Plaintiff Deadline in the Securities Fraud Class Action

08.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. - BIOA

03.01.25PR NewswireBioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO- Hagens Berman

02.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. - BIOA

27.12.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. - BIOA

BioAge Labs News

BioAge Labs News: auf dieser Seite finden Sie alle BioAge Labs News und Nachrichten zur BioAge Labs Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch BioAge Labs News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um BioAge Labs News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.